Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PSEN2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 72 | 33 |
|
Leukodystrophy and Leukoencephalopathy, Adult Onset Panel PreventionGenetics, part of Exact Sciences United States | 67 | 45 |
|
Dilatative Cardiomyopathy Panel (DCM Panel) Labor Dr. Wisplinghoff Germany | 43 | 43 |
|
Genologica Medica Spain | 25 | 10 |
|
Dementia panel. NGS panel of 21 genes. Genologica Medica Spain | 44 | 21 |
|
Alzheimer's panel. NGS panel of 10 genes. Genologica Medica Spain | 25 | 10 |
|
Alzheimer Disease, PSEN2 Genetic Analysis, Alzheimer Type 4 Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
Arrhythmia & Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 211 | 93 |
|
Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 170 | 71 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 134 | 48 |
|
Dilated cardiomyopathy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 45 | 35 |
|
Cardiomyopathy, dilated type 1V Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.